Insider Transactions in Q4 2024 at Upstream Bio, Inc. (UPB)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2024
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
825,000
+12.66%
|
$14,025,000
$17.0 P/Share
|
|
Oct 15
2024
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
3,609,789
+42.58%
|
-
|
|
Oct 15
2024
|
Erez Chimovits Director |
BUY
Open market or private purchase
|
Indirect |
825,000
+12.66%
|
$14,025,000
$17.0 P/Share
|
|
Oct 15
2024
|
Erez Chimovits Director |
BUY
Conversion of derivative security
|
Indirect |
3,609,789
+42.58%
|
-
|
|
Oct 15
2024
|
Ai Upstream LLC |
BUY
Conversion of derivative security
|
Direct |
4,319,410
+29.86%
|
-
|
|
Oct 15
2024
|
Ai Upstream LLC |
BUY
Open market or private purchase
|
Direct |
1,175,000
+50.0%
|
$19,975,000
$17.0 P/Share
|
|
Oct 15
2024
|
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. |
BUY
Conversion of derivative security
|
Direct |
894,733
+50.0%
|
-
|